glp-1 agonists with cardiovascular benefit Receptor in the Rehabilitation of Patients Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives GLP-1 Agonists in Cardiovascular Diseases:
Description
Image Credit: Love Employee / Shutterstock In a recent study published in JCO Oncology Practice , researchers explored the impact of glucagon-like peptide-1 receptor agonist (GLP-1 RA) use on breast cancer incidence
Post-Diagnosis Weight Gain Significantly Increases Mortality Risk The rationale for aggressive weight management in breast cancer is rooted in its prognostic impact
Hence, their use in different regions is increasing
00203-5/asset/a0abd16a-3eaa-4d78-990d-ba94939c04c6/main.assets/gr2_lrg.jpg)
3e, Supplementary Table 4)
Setting Denmark, Norway, and Sweden, 2007-21
